Loncastuximab Tesirine in WM

Clinical trial NCT05190705 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05190705
Sponsor: Shayna Sarosiek, MD
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Waldenstrom Macroglobulinemia

Start date: 2022-02-17
Primary completion: 2026-05-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.